Genesco (GCO) Stock Forecast, Price & News

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Genesco in the last year. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" GCO shares.
View GCO analyst ratings or view top-rated stocks.

Genesco's stock was trading at $46.02 at the beginning of the year. Since then, GCO stock has decreased by 58.9% and is now trading at $18.90.
View the best growth stocks for 2023 here.

Genesco saw a increase in short interest in the month of May. As of May 15th, there was short interest totaling 599,200 shares, an increase of 29.3% from the April 30th total of 463,400 shares. Based on an average daily volume of 191,900 shares, the days-to-cover ratio is presently 3.1 days. Approximately 5.1% of the company's stock are short sold.
View Genesco's Short Interest.

The company is scheduled to release its next quarterly earnings announcement on Thursday, September 7th 2023.
View our GCO earnings forecast.

Genesco Inc. (NYSE:GCO) released its earnings results on Thursday, May, 25th. The company reported ($1.59) EPS for the quarter, missing the consensus estimate of ($1.10) by $0.49. The company had revenue of $483.60 million for the quarter, compared to analysts' expectations of $478.01 million. Genesco had a trailing twelve-month return on equity of 8.05% and a net margin of 2.05%. Genesco's quarterly revenue was down 7.1% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.44 EPS.

ETFs with the largest weight of Genesco (NYSE:GCO) stock in their portfolio include Invesco S&P SmallCap Value with Momentum ETF (XSVM), Invesco S&P SmallCap 600 Pure Value ETF (RZV), SPDR S&P Retail ETF (XRT), Direxion Daily Retail Bull 3X Shares (RETL), Invesco S&P SmallCap Consumer Discretionary ETF (PSCD), Invesco S&P SmallCap Quality ETF (XSHQ), Invesco S&P SmallCap 600 Revenue ETF (RWJ) and

Genesco updated its FY 2024 earnings guidance on Tuesday, May, 30th. The company provided EPS guidance of $2.00-$2.50 for the period, compared to the consensus estimate of $5.39. The company issued revenue guidance of $2.27 billion-$2.29 billion, compared to the consensus revenue estimate of $2.41 billion.

8 employees have rated Genesco Chief Executive Officer Mimi Vaughn on Glassdoor.com. Mimi Vaughn has an approval rating of 70% among the company's employees.

Based on aggregate information from My MarketBeat watchlists, some companies that other Genesco investors own include CA (CA), BlackRock (BLK), Endologix (ELGX), Intelsat (I), Ciena (CIEN), Chipotle Mexican Grill (CMG), Transocean (RIG), Bank of America (BAC), Micron Technology (MU) and Workday (WDAY).

Genesco trades on the New York Stock Exchange (NYSE) under the ticker symbol "GCO."

Genesco's stock is owned by many different institutional and retail investors. Top institutional shareholders include BlackRock Inc. (16.44%), Dimensional Fund Advisors LP (8.21%), State Street Corp (4.35%), Legion Partners Asset Management LLC (3.33%), LSV Asset Management (2.52%) and Ameriprise Financial Inc. (2.44%). Insiders that own company stock include Daniel E Ewoldsen, Kathleen Mason, Marty G Dickens, Mimi Eckel Vaughn, Thomas George and Thurgood Marshall Jr.
View institutional ownership trends.

Shares of GCO stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of GCO stock can currently be purchased for approximately $18.90.

Genesco (NYSE:GCO) has a market capitalization of $237.44 million and generates $2.35 billion in revenue each year. The company earns $71.92 million in net income (profit) each year or $3.85 on an earnings per share basis.

The company employs 19,000 workers across the globe.

Genesco's mailing address is Genesco Park 1415 Murfreesboro Pike, NASHVILLE TN, 37217. The official website for the company is www.genesco.com. The company can be reached via phone at (615) 367-7000, via email at investorrelations@genesco.com, or via fax at 615-367-8579.